FDG-PET/CT in re-staging of patients with lymphoma
- 26 November 2003
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 31 (3), 325-329
- https://doi.org/10.1007/s00259-003-1375-y
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantationBlood, 2003
- Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncologyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin’s lymphomaAnnals of Oncology, 2002
- PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease.2002
- Dual-modality PET/CT tomography for clinical oncology.2002
- Image Analysis in Patients with Cancer Studied with a Combined PET and CT ScannerClinical Nuclear Medicine, 2000
- Anatomy of SUVNuclear Medicine and Biology, 2000
- The lymphomas.1999
- Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomasEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- Computed tomography of abdominal paraaortic lymph node disease: preliminary observations with a 6 second scannerAmerican Journal of Roentgenology, 1977